share_log
Reuters ·  Apr 26 11:43
Vertex Announces European Commission Approval for Kalydeco® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment